Cart summary

You have no items in your shopping cart.

Sapitinib

SKU: orb1301080

Description

Sapitinib (AZD-8931) is a potent, ATP-competitive inhibitor of EGFR, ErbB2, and ErbB3 with single-digit nM IC50 values. It demonstrates superior activity to gefitinib or lapatinib in NSCLC cells and exhibits high selectivity for the ErbB family over kinases like MNK1 and Flt. This compound is a valuable tool for in vitro and in vivo studies exploring ErbB signaling in cancer research.

Research Area

Cardiovascular Research, Signal Transduction

Images & Validation

Key Properties

CAS Number848942-61-0
MW473.93
Purity98.89%
FormulaC23H25ClFN5O3
SMILESCNC(=O)CN1CCC(CC1)Oc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC
TargetEGFR
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.22 mM);DMSO:40 mg/mL (84.4 mM);H2O:< 1 mg/mL (insoluble or slightly soluble);Ethanol:< 1 mg/mL (insoluble or slightly soluble)

Bioactivity

Target IC50
EGFR:4 nM|ERB3:4 nM|ErbB2:3 nM
In Vivo
Sapitinib reveals antitumor activity in BT474c, Calu-3, LoVo, FaDu and PC-9 xenografts. Sapitinib could reduce p-Akt, Ki67 expression and p-ERK in BT474c xenografts following acute treatment. Sapitinib also causes induction of the M30 apoptosis marker. Furthermore, Sapitinib shows greater proapoptotic effect compared with gefitinib and lapatinib in LoVo xenografts.
In Vitro
Sapitinib shows different potency to NSCLC and SCCHN cell lines. Sapitinib has high sensitivity to PC-9 cells (EGFR activating mutation) with GI50 of 0.1 nM and low activity to NCI-1437 cells with GI50 above 10 μM. Sapitinib exhibits more potency against phospho-EGFR, phospho-erbB2 and phospho-erbB3 than either lapatinib or gefitinib in PE/CA-PJ41, PE/CA-PJ49, DOK and FaDu cells.
Cell Research
To determine the antiproliferative activity against cell lines grown in vitro, AZD8931 is tested in a panel of NSCLC and SCCHN cell lines. Cells are incubated for 96 hours with AZD8931 (0.001-10 μM). Viable cell number is determined by 4 hours of incubation with MTS Colorimetric Assay reagent and absorbance measured at 490 nm on a spectrophotometer. (Only for Reference)

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Sapitinib, AZD 8931, AZD8931, AZD-8931, Inhibitor, HER2/ErbB2, HER1, EGFR, Epidermal growth factor receptor, ErbB-1, inhibit

Similar Products

  • Sapitinib [orb1223864]

    >98% (HPLC)

    848942-61-0

    473.9

    C23H25ClFN5O3

    1 g, 500 mg, 200 mg, 100 mg, 2 mg, 10 mg, 50 mg, 5 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Sapitinib (orb1301080)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

2 mg
$ 80.00
1 ml x 10 mM (in DMSO)
$ 100.00
5 mg
$ 100.00
10 mg
$ 120.00
25 mg
$ 160.00
50 mg
$ 210.00
100 mg
$ 300.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry